Generalmente, las dosis varan entre 500 mg y 3000 mg diarios, dependiendo del objetivo
Researchers have studied the safety of tirzepatide in various contexts, and while all medications can have side effects, no major safety issues have consistently emerged with this drug
Differential gene expression between clusters was performed using the FindMarkers function
This dual action supports improved blood sugar regulation and appetite control
The 'Switch' is On: Proving the Viability of Oral Maintenance Therapy The ATTAIN-MAINTAIN study was a first-of-its-kind Phase 3 trial designed to answer a critical clinical question: can patients who have successfully lost weight on injectable GLP-1s (Wegovy or Zepbound) switch directly to an oral agent and maintain their results
Lam KK, Zheng X, Forestieri R, Balgi AD, Nodwell M, Vollett S, Anderson HJ, Andersen RJ, Av-Gay Y, Roberge M